Navigation Links
Newly Patented Sterilization/Disinfection Method Reduces Risk of Microorganism Growth on Hard Surfaces
Date:7/21/2009

Bauer Energy Design® Inc. ("Bauer" or the "Company") is pleased to announce today that the U.S. Patent and Trademark Office has granted US Patent No. 7,547,413 to Bauer. This U.S. patent includes broad claims to novel methods and systems and their use in disinfecting or sterilizing a surface, an object or an environment with a special treated water steam.

Waterloo, Ontario, Canada (PRWEB) July 22, 2009 -- Bauer Energy Design® Inc. ("Bauer" or the "Company") is pleased to announce today that the U.S. Patent and Trademark Office has granted US Patent No. 7,547,413 to Bauer. This U.S. patent includes broad claims to novel methods and systems and their use in disinfecting or sterilizing a surface, an object or an environment with a special treated water steam.

The issuance of this patent provides broad patent protection for our water and steam vapour processing system and creates commercial opportunities for Bauer and his licensees in a broad commercial space. "Our system has applications in industry, including health care, livestock farms, meat processors, food manufacturers, food service facilities, schools and universities, as well as in domestic households," said Walter J. Bauer, President of the Company. Bauer's patent portfolio now includes one issued patent and two patent applications pending in multiple jurisdictions throughout the world.

Surface-mediated infectious disease transmission is a major concern in a variety of settings, including schools, hospitals, and food-processing facilities. Chemical disinfectants frequently used to reduce contamination pose significant risks to humans and the environment. Some microorganisms have natural resistance to chemical disinfectants which operate over a narrow range of pathogens. Additionally, the chemical formulations require long dwell or exposure times which are often overlo
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. First study examines newly-licensed RN work attitudes and intentions
2. Common abdominal pain may be due to a potentially treatable newly recognized inflammatory reaction
3. Higher death rates in kidney patients with newly recognized disease
4. Newly Published Study in Leading Medical Journal Further Confirms the Brava Systems Non-Surgical Breast Enhancement Effectiveness
5. Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
6. Corrected & Replaced - Natural Nutrition Expands Revenue Capabilities with Newly Installed State of the Art Nutrition Bar Line
7. Hidden Costs Plague Owners Occupying Newly Constructed Buildings; New Program Can Help Avoid Major Issues
8. Striking shift seen among newly HIV-infected men regarding partners
9. Newly HIV-Infected Gay Men Select Other Infected Partners
10. Thalidomide Added to Standard Therapy Prolongs Overall Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
11. New therapeutic options for newly diagnosed multiple myeloma patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... is relative, especially to people who tend to be ... Medical Center in the US found that seven in ... People of normal weight make this mistake much less ... to misjudge their children,s size, as youngsters misjudge their ... at Weill-Cornell Medical College, in a study in the ...
(Date:9/16/2014)... study that compared patient-reported outcomes of a broad ... that single fraction radiation therapy (SFRT) is equally ... when pain, function and quality of life are ... American Society for Radiation Oncology,s (ASTRO,s) 56th Annual ... patients, pain, function and degree of distress were ...
(Date:9/16/2014)... While abnormalities in the adrenergic and noradrenergic systems, ... to play a role in the development of ... been no genetic evidence of this connection. A ... University,s Mailman School of Public Health and the ... ADRB2 gene and childhood adversity. For individuals with ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Beginning October 1st ... a new service offering for its clients who book a ... the volume of business they buy. Most recurring visit ... during the work week, but others include clients whose unique ... pet sitter on a daily basis. The newly ...
(Date:9/16/2014)... Philadelphia, PA (PRWEB) September 16, 2014 ... #1 Pain Management practice by Ranking Arizona magazine, has ... for implementation across its enterprise. , With TPC ... had a vast data repository that was managed through ... for both the management and clinical leadership teams. ...
Breaking Medicine News(10 mins):Health News:Poor body size judgement can lead to increased tolerance of obesity 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 2Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 3Health News:Single fraction RT as effective as multiple fraction RT for bone metastases 4Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 2Health News:Evidence of genetic link to PTSD in soldiers exposed to childhood trauma 3Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 2Health News:Dallas-based Park Cities Pet Sitter Introduces New 15-Minute Visit for Clients on Recurring Visit Schedules. 3Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 2Health News:The Pain Center of Arizona (TPC) Implements Analance™ BI for Actionable Intelligence 3
... , MORRISTOWN, N.J., Dec. 2 ... announced that the Federal Trade Commission (FTC) has accepted a ... acquisition of privately held Arrow Group and has granted early ... the parties to close the transaction. The parties have ...
... , NASHVILLE, Tenn., Dec. 2 ... company, has appointed Pearson Talbert as chief development officer. ... will provide leadership and vision to the sales and ... hospitals grow revenues through employer partnerships and physician relationships. ...
... , MORRISTOWN, N.J., Dec. 2 Watson Pharmaceuticals, Inc. (NYSE: ... the acquisition of Arrow Group for a combination of cash ... pharmaceutical company with over $3 billion in annual revenues and ... several significant benefits to Watson shareholders as a result of ...
... taking it for macular degeneration is not advised, ... Women who take low-dose aspirin to protect their heart ... new study by Harvard University researchers found what they ... age-related macular degeneration (AMD), an eye disease that destroys ...
... ... Lighting Sunday, December 13 to remember all children who died. Hundreds of services open to ... many believe is the world,s largest mass candle lighting. , ... Oak Brook IL (PRWEB) December 2, 2009 -- Tens of ...
... ... to do better, be better and take better self-care. What to do to ensure the ... make self-care the #1 priority. At Garden of Eve safe skin care is the primary ... consumer guide to safe cosmetic products. , ...
Cached Medicine News:Health News:Watson Receives FTC Clearance for Arrow Acquisition 2Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:Watson Completes Acquisition of Arrow Group 2Health News:Watson Completes Acquisition of Arrow Group 3Health News:Watson Completes Acquisition of Arrow Group 4Health News:Watson Completes Acquisition of Arrow Group 5Health News:In Women, Aspirin Might Ward Off Eye Trouble 2Health News:Bereaved Families Unite for Compassionate Friends Worldwide Candle Lighting 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 2Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 3Health News:The New Year's Resolution that Fuels Them All: Self-Care; Garden of Eve Makes Self-Care Through Safe Skin Care # 1 Priority 4
(Date:9/16/2014)... , Sept. 16, 2014 The Lupus ... LLY ) today released results from UNVEIL: ... sheds light on the lupus journey and the challenges ... for lupus caregivers. The UNVEIL study, which involved over ... devastating impact lupus has on all aspects of life ...
(Date:9/16/2014)... DIEGO , Sept. 16, 2014 Imprimis ... pharmaceutical company dedicated to delivering high quality and novel ... announced that Chief Executive Officer Mark Baum ... Annual Craig-Hallum Alpha Select Conference in New York City.  ... its Go Dropless™ campaign in ophthalmology. The presentation ...
(Date:9/16/2014)... -- Relmada Therapeutics, Inc., (OTCBB: RLMD), a clinical-stage company developing ... today that it has entered into an agreement with ... of animal studies for levorphanol, the active ingredient of ... levorphanol.  Gavril Pasternak, MD, PhD, of MSKCC is the ... Pasternak said, "Levorphanol is a unique opioid analgesic that ...
Breaking Medicine Technology:"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... COLLEGEVILLE, Pa., May 30 Wyeth,Pharmaceuticals, a ... today announced the,initiation of the INTORACT (INvestigation ... worldwide randomized, open-label, phase 3b,study comparing TORISEL(R) ... for first-line treatment of patients,with advanced renal ...
... evaluation of safety and tolerability, as ... 2 trials -, ROCKVILLE, Md., May 30 ... that it has initiated dosing in a Phase,1 clinical ... lead IAP,inhibitor, HGS1029, as monotherapy in patients with advanced ...
Cached Medicine Technology:Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 2Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 3Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 4Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 5Wyeth Initiates INTORACT -- A New Clinical Trial to Examine TORISEL Plus Avastin for First-Line Treatment of Advanced Kidney Cancer 6Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 2Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 3Human Genome Sciences Initiates First Clinical Trial of Lead IAP Inhibitor HGS1029 in Advanced Solid Tumors 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: